Hansa Biopharma AB (publ) (FRA:24H)
Germany · Delayed Price · Currency is EUR 2.524
-0.204 (-7.48%)
At close: Dec 19, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of €275.08 million as of December 19, 2025. Its market cap has increased by 48.95% in one year.
Market Cap
275.08M
Enterprise Value
336.89M
Revenue
16.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.52
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 3.30M to 275.08M, an increase of 8,245.59%. That is a compound annual growth rate of 28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 275.08M | 18.58% |
| Dec 30, 2024 | 231.97M | 88.20% |
| Dec 29, 2023 | 123.25M | -46.81% |
| Dec 30, 2022 | 231.71M | -39.91% |
| Dec 30, 2021 | 385.60M | -63.68% |
| Dec 30, 2020 | 1.06B | 230.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |